Skip to main content

Integrin-mediated internalization of Staphylococcus aureus does not require vinculin



Disease manifestations of Staphylococcus aureus are connected to the fibronectin (Fn)-binding capacity of these Gram-positive pathogens. Fn deposition on the surface of S. aureus allows engagement of α5β1 integrins and triggers uptake by host cells. For several integrin- and actin-associated cytoplasmic proteins, including FAK, Src, N-WASP, tensin and cortactin, a functional role during bacterial invasion has been demonstrated. As reorganization of the actin cytoskeleton is critical for bacterial entry, we investigated whether vinculin, an essential protein linking integrins with the actin cytoskeleton, may contribute to the integrin-mediated internalization of S. aureus.


Complementation of vinculin in vinculin -/- cells, vinculin overexpression, as well as shRNA-mediated vinculin knock-down in different eukaryotic cell types demonstrate, that vinculin does not have a functional role during the integrin-mediated uptake of S. aureus.


Our results suggest that vinculin is insignificant for the integrin-mediated uptake of S. aureus despite the critical role of vinculin as a linker between integrins and F-actin.


Staphylococcus aureus is often associated with nosocomial infections, which can lead to life threatening conditions such as acute endocarditis and bacteremia. Pathogenesis by S. aureus involves several bacterial virulence factors including exotoxins and adhesins [1]. Six different adhesins of S. aureus (FnBPA, FnBPB, Eap, Emb, Ebh and Aaa/Sle1) were found to bind to the extracellular matrix (ECM) protein fibronectin [2]. In particular, bacterial cell wall anchored fibronectin binding proteins (FnBPs) can capture soluble fibronectin from host plasma [3]. Binding to fibronectin is mediated by several repeats within FnBP, which interact with the amino-terminal fibronectin type I domains of this host glycoprotein [4]. Via an RGD motif within one of the fibronectin type III domains, S. aureus-associated fibronectin is able to bind with high affinity to integrin α5β1. Accordingly, fibronectin can serve as a molecular bridge connecting S. aureus with host cell receptors [5, 6]. Moreover, the FnBP-fibronectin mediated engagement of integrins triggers internalization of the microbes by non-professional phagocytes such as epithelial cells, endothelial cells, keratinocytes, and fibroblasts [710]. Several investigations demonstrate the importance of the FnBP-mediated invasion process in vivo. In a rat model of endocarditis, S. aureus strains with reduced fibronectin-binding capacity showed a decreased ability to colonize damaged heart valves [11]. In addition, FnBP expression enhances the capacity of S. aureus to colonize mammary glands and invade mammary epithelial cells in a mouse model of mastitis [12]. Exogenous expression of S. aureus FnBP in non-pathogenic Lactobacillus lactis allows these bacteria to colonize damaged heart valves and to spread to the spleen in a mouse model of endocarditis [13]. Therefore, FnBP-mediated host cell contact and cellular invasion appear to contribute to S. aureus survival and persistence within the infected host [14]. As FnBP-related proteins are found in other human pathogens and as integrin-mediated host cell internalization appears critical for certain manifestations of S. aureus infections, a better understanding of the molecular mechanisms guiding FnBP-initiated uptake is warranted.

We and others have previously shown that fibronectin deposition on the surface of S. aureus allows engagement of α5β1 integrins and triggers the recruitment of actin- and focal adhesion-associated proteins such as paxillin, zyxin, tensin, cortactin, N-WASp, Arp2/3, and FAK to the sites of bacterial attachment [5, 15, 16]. For several of these proteins, including N-WASP, tensin, FAK and cortactin, a functional role during integrin-mediated uptake of S. aureus has been demonstrated [15, 16]. As reorganization of the actin cytoskeleton is crucial for the internalization process [9, 10, 17], it is assumed that dynamic regulation of F-actin by these proteins contributes to bacterial uptake.

Vinculin is one of the characteristic actin-binding proteins recruited to integrin-rich focal adhesion sites, which mechanically links integrin cytoplasmic tails with the actin cytoskeleton [18, 19]. Vinculin has no enzymatic activity and its functions are regulated by a conformational switch between a closed (inactive) conformation, mediated by an intramolecular head-tail interaction, and an open (active) state [20]. In the open conformation, the vinculin head and tail domains dissociate, allowing multiple interactions with additional proteins or phospholipids [21]. For example, talin, α-actinin, VASP, paxillin, phosphatidylinositol-4,5-bisphosphate, and F-actin bind to active vinculin [18]. In addition, vinculin may promote actin filament nucleation by recruiting the Arp2/3 complex to integrin tails [22]. Furthermore, depending on the conformational state, vinculin can also act as an F-actin barbed end capping protein [23]. A role for vinculin during bacterial entry has been reported in the case of Shigella flexneri. Upon contact with epithelial cells, S. flexneri injects the IpaA protein into the host cell cytoplasm, where IpaA directly binds to vinculin inducing a dramatic rearrangement of the actin cytoskeleton to promote bacterial engulfment [24, 25]. Vinculin has also been observed to be recruited to S. aureus–host cell contact sites or fibronectin-coated beads in epithelial, but not in endothelial cells [15, 16, 22]. However, it has not been investigated if vinculin has a functional role during integrin-mediated internalization of S. aureus into host cells.

In this report, we analyze the contribution of vinculin to FnBP-mediated uptake of S. aureus in different human and murine cell types. Surprisingly, re-expression of vinculin in vinculin-deficient fibroblasts as well as shRNA-mediated knock-down of this protein in different cell types do not affect bacterial uptake demonstrating that vinculin is completely dispensable for bacterial internalization via integrin α5β1. Therefore, our results suggest that actin cytoskeleton rearrangements during integrin-mediated endocytosis do not require vinculin function despite the well characterized role of vinculin as a linker between integrins and F-actin.


Enhanced cell invasion of S. aureus into vinculin knock-out fibroblasts correlates with increased integrin α5 surface expression

Murine embryonic fibroblasts with a genetic deletion of vinculin (vinculin -/- cells) have been generated and been used in a previous study [26]. When grown on a fibronectin-coated surface, vinculin -/- cells spread more slowly and form smaller, less stable focal adhesions compared to wildtype fibroblasts (vinculin WT cells) or vinculin -/- cells re-expressing vinculin [27, 28]. Total internal reflection fluorescence (TIRF) microscopy demonstrates that vinculin is located in well-organized, peripheral focal adhesions in vinculin WT cells. In vinculin -/- cells, no staining with the monoclonal α-vinculin antibody was observed (Figure1A). The absence of vinculin was accompanied by a reduced size and an altered distribution of integrin β1-containing focal adhesions at the cell-substrate interface (Figure1A). Compared to vinculin -/- cells, vinculin WT cells showed concentration of large integrin β1-containing focal adhesions in the cell periphery (Figure1A). However, the overall amount of active integrin β1 did not differ between vinculin WT and vinculin -/- cells as detected by a conformation-specific monoclonal antibody (Additional file1: Figure S1). The lack of vinculin in whole cell lysates (WCLs) prepared from vinculin -/- cells was also confirmed by Western blotting (Figure1B). Importantly, expression of several known focal adhesion proteins and vinculin binding partners such as talin, FAK, paxillin, and Src was not altered by the absence of vinculin (Figure1B). Equal loading of cell lysates for Western blotting was confirmed by probing for β-tubulin (Figure1B). To test for a functional role of vinculin in the integrin-mediated internalization of bacteria, we infected these fibroblasts with pathogenic S. aureus strain Cowan, which connects to the host cell receptor integrin α5β1 by binding to the integrin ligand fibronectin. As a negative control, we used non-pathogenic S. carnosus, which lacks a fibronectin binding adhesin and which does not invade host cells [5, 15]. As expected, host cell adhesion and invasion assays confirmed that S. carnosus was unable to invade fibroblasts, whereas S. aureus attached to and invaded vinculin WT cells (Figure1C and D). Unexpectedly, vinculin -/- cells showed significantly increased numbers of cell-associated S. aureus (Figure1C) and about 40% increase in host cell invasion (Figure1D). As vinculin -/- cells have undergone several rounds of selection during their establishment [28], compensatory mechanisms might have occurred in the absence of vinculin. In particular, vinculin -/- cells supported increased cell-association of S. aureus (Figure1C), suggesting that the availability of the involved host cell receptor, integrin α5β1, might be altered in these cells. Therefore, expression of different integrin subunits on the surface of vinculin WT and vinculin -/- cells were investigated by flow cytometry. Whereas integrin β1 was present in similar amounts in both cell lines, a strongly increased surface expression of integrin α5 and a reduced expression of the integrin αv subunit was detected in vinculin -/- cells (Figure1E). Elevated amounts of integrin α5 transcripts were also detected in vinculin -/- cells by quantitative real-time PCR (Figure1F). The altered integrin α5 expression in vinculin -/- cells correlated with the enhanced host cell binding of S. aureus. Together, these results suggested that the altered integrin expression profile of vinculin WT compared to vinculin -/- cells, and not the absence of vinculin, might be responsible for the observed differences in host cell invasion by S. aureus in these murine fibroblast lines.

Figure 1

Increased integrin α5 expression correlates with enhanced bacterial adherence and uptake in vinculin -/- cells. (A) Vinculin WT and vinculin -/- cells were seeded on fibronectin coated glass bottom imaging dishes, next day fixed and stained for vinculin expression using α-human vinculin antibody (clone hVIN1). Total amounts of integrins were stained using integrin β1 antibody (clone HMβ1-1). TIRF microscopy was used to assess the localization of vinculin and β1 integrins. Bars represent 10 μm. (B) Equal amounts of protein in the whole cell lysates (WCL) of vinculin WT and vinculin -/- cells were separated by SDS-PAGE and processed for Western blotting using antibodies against talin, FAK, vinculin, paxillin, Src, or β-tubulin as indicated. Representative blots are shown. (C and D) Cells were seeded on gelatine coated 24 well plates and infected with S. aureus or S. carnosus with MOI 20 for 2 h. Total cell associated or recovered viable intracellular bacteria were determined by bacterial cell adhesion (C) or gentamicin protection assays (D), respectively. Values are means ± SEM from 5 independent experiments done in quadruplicate (n=20). Statistical significance of data was assessed by Mann-Whitney test. (E) Cells were stained for surface expression of β1, α5, αv, or β3 integrins and examined by flow cytometry. Data are shown as mean fluorescence intensity (MFI) and are corrected for the background MFI of integrin β1 -/- fibroblasts (β1 integrin staining) or corrected for the MFI of cells stained in the absence of primary antibody (α5, αv, and β3 integrin stainings). Results are shown as mean ± SEM from 3 independent experiments. (F) mRNA levels of β1, α5, αv, or β3 integrin transcripts in vinculin WT or vinculin -/- cells were analyzed by qRT-PCR. Integrin expression was normalized to GAPDH expression and was set to 1 for vinculin WT cells. Bars represent the mean of two independent experiments each performed in triplicate.

Re-expression of vinculin in vinculin -/- fibroblasts does not affect bacterial entry

To address the contribution of vinculin for host cell invasion of S. aureus in an identical cellular context, we transiently transfected vinculin -/- cells with a construct encoding enhanced green fluorescent protein (GFP)-tagged murine vinculin. As a control, an GFP encoding vector was used. 48 h post-transfection, cells seeded on gelatine-coated coverslips were infected with S. aureus (MOI 50) for 2 h, fixed and, after blocking with 10% fetal calf serum in PBS, extracellular bacteria were stained by rabbit α-staphylococcal serum and goat α-rabbit antibody coupled to Cy5. After cell permeabilization, total cell-associated bacteria were stained by applying rabbit α-staphylococcal serum and Cy3-coupled goat α-rabbit antibody. The double cycle antibody staining according to this established protocol enables the discrimination between intracellular and extracellular bacteria [29, 30]. Fluorescence microscopy pictures revealed that a fraction of GFP-vinculin, but not GFP, localized at focal adhesion sites in the transiently transfected vinculin -/- cells (Figure2A). Moreover, vinculin re-expression was accompanied by a morphological change to a more spread phenotype (Figure2A). Nevertheless, both GFP as well as GFP-vinculin expressing cells harbored intracellular bacteria (Figure2A). Enumeration of cell-associated extracellular or intracellular bacteria in GFP versus GFP-vinculin transfected cells demonstrated that bacterial binding and uptake into these cells occurred at a similar level (Figure2B). Thus, the transient re-expression of vinculin in vinculin -/- cells changes the spreading of the cells, without altering bacterial uptake, indicating that vinculin may not contribute to the internalization of S. aureus.

Figure 2

S. aureus internalization is not affected by transient expression of vinculin in vinculin -/- cells. (A) Vinculin -/- fibroblasts were transfected with GFP or GFP-vinculin encoding constructs. 24 h post-transfection, cells were infected with S. aureus at MOI 50 for 2 h, fixed and stained for extracellular vs. intracellular bacteria. Representative fluorescence microscopy pictures show intracellular (arrowhead) as well as cell-associated, extracellular (small arrow) S. aureus. (B) Cells were transfected, infected, and stained as in (A) and extra- and intracellular bacteria were quantified. Values are presented as mean ± SEM from 2 independent experiments and based on 100 cells/sample. Data were analyzed for statistical significance using Kruskal-Wallis test.

Vinculin overexpression does not influence the uptake of S. aureus in human cells

Our results that vinculin might not be necessary for integrin-mediated uptake by murine cells were surprising, given by the fact that vinculin is recruited to the sites of bacterial entry in human cells and has a role in F-actin organization and focal adhesion turnover [15, 28]. To analyze weather vinculin is functionally involved in S. aureus invasion into human cells, we transiently transfected 293T cells to express GFP or GFP-vinculin, respectively. Western blotting with vinculin antibodies confirmed that total vinculin levels were augmented ~10-fold following transfection with GFP-vinculin (~145 kDa) compared to the endogenous levels of vinculin (~120 kDa) in the GFP transfected cells (Figure3A). Equal loading of proteins from both samples was confirmed by probing for β-tubulin (Figure3A). Expression levels of integrin α5 were only slightly increased in response to vinculin overexpression (Figure3B). Transfected cells were also seeded on gelatine-coated wells and infected at MOI 20 for 2 h with the FnBP-expressing S. aureus or the non-invasive S. carnosus. Total cell-associated bacteria as well as the numbers of viable intracellular bacteria were then determined. In agreement with our previous observations, the amounts of total cell-associated (Figure3C), as well as the viable intracellular bacteria were unaltered by vinculin overexpression (Figure3D). These results demonstrate that vinculin overexpression does not modulate S. aureus entry into human cells. These data also indicate that vinculin is not a limiting factor for the integrin-mediated uptake of these fibronectin-binding bacteria and further suggest that the differences observed between murine vinculin WT and vinculin -/- cells might be due to alterations in the expression pattern of integrin subunits.

Figure 3

Transient vinculin overexpression in 293 cells does not interfere with bacterial uptake. (A) 293 cells were transfected with constructs encoding GFP or GFP-vinculin. 48 h post-transfection whole cell lysates (WCLs) were prepared and analyzed for vinculin and β-tubulin expression by immunoblotting. Representative blots are shown. (B) Cells transfected as in (A) were compared for integrin α5 surface expression by flow cytometry. Shown is a representative histogram of cells stained with α-integrin α5 antibody and a rhodamine-coupled secondary antibody (blue – GFP; red – GFP-vinculin) or cells stained with the secondary antibody only (grey lines). (C and D) Cells as in (A) were infected with S. aureus and S. carnosus for 2 h (MOI 20). Total cell associated or recovered viable intracellular bacteria were determined by bacterial cell adhesion (C) or gentamicin protection assays (D), respectively. Values are means ± SEM from 2 independent experiments done in quadruplicate, n=8. Mann-Whitney test was applied for statistical significance testing.

ShRNA-mediated vinculin silencing does not interfere with S. aureus internalization

Though vinculin is not limiting for S. aureus uptake, endogenous levels of this protein might still be needed to support internalization. Therefore, we investigated whether shRNA-mediated knock-down of vinculin might interfere with S. aureus uptake. To this end, we generated murine fibroblasts stably transduced with recombinant lentiviral particles harboring the empty plasmid pLKO.1 or the plasmid pLKO.1 encoding shRNA against murine vinculin (pLKO.1 sh-mvinc). After puromycin selection, the successful vinculin knock-down in the transduced cell population was verified by Western blotting. Importantly, complete inhibition of mouse vinculin expression, but unaltered expression of FAK, Src or paxillin was detected (Figure4A). Furthermore, surface levels of integrin α5 were similar in vinculin-deficient and vinculin-expressing fibroblasts (Figure4B). Next, we were interested if the vinculin knock-down could affect interaction of the bacteria with host cells with regard to cell attachment and internalization. Accordingly, pLKO.1 and pLKO.1 sh-mvinc fibroblasts were infected with S. aureus and the amount of total cell-associated as well as the number of viable intracellular bacteria was determined (Figure4C). Though the amounts of cell-associated bacteria were decreased in pLKO.1 sh-mvinc fibroblasts compared to control cells, the number of intracellular bacteria in both cell populations was equal. The results from the bacterial adhesion assay correlated with the slightly decreased expression of integrin α5 on the surface of vinculin knock-down cells, compared to control cells (Figure4B).

Figure 4

Knock-down of vinculin in wildtype fibroblasts does not affect S. aureus uptake. (A) Murine fibroblasts were transduced with lentiviral particles harboring either pLKO.1 or pLKO.1 encoding shRNA against mouse vinculin (pLKO-1 sh-mvinc). WCL of the stably transduced cell lines were analyzed for FAK, vinculin, paxillin, Src and β-tubulin protein expression by Western blotting. Representative blots are shown. (B) Integrin α5 surface expression in cells from (A) was analyzed by flow cytometry. Shown is a representative histogram of cells stained with α-integrin α5 antibodies and a rhodamine-coupled secondary antibody (blue – pLKO.1; red – pLKO.1 sh-mvinc) or cells stained with the secondary antibody only (contr.; grey lines). (C) pLKO.1 or pLKO.1 sh-mvinc cells were seeded on gelatine coated 24 well plates. Next day, cells were infected with S. aureus at MOI 20 for 2 h. Total cell associated or recovered viable intracellular bacteria were determined by bacterial cell adhesion (top) or gentamicin protection assays (bottom), respectively. Values are means ± SEM from 2 independent experiments done in quadruplicate, n=8. Mann-Whitney test was applied for statistical testing.

In a second parallel approach, we generated 293 cells stably transduced with recombinant lentiviral particles harboring the empty plasmid pLKO.1 or with particles harboring plasmid pLKO.1 encoding shRNA against human vinculin (pLKO.1 sh-hvinc). After puromycin selection, pLKO.1 sh-hvinc cells showed no detectable vinculin expression in whole cell lysates, but no alteration in FAK, Src and paxillin expression (Figure5A). Functional assays of bacterial interaction with host cells revealed that knock-down of vinculin in these human cells again did not influence their ability to support fibronectin-mediated cell attachment or internalization of S. aureus (Figure5B and C).

Figure 5

Vinculin knock-down in 293 cells does not affect the uptake of S. aureus. (A) 293 cells were stably transduced with pLKO.1 or pLKO.1 encoding shRNA against human vinculin (pLKO.1 sh-hvinc). Whole cell lysates were prepared and WCLs were analyzed by Western blotting for vinculin, FAK, paxillin, Src, and β-tubulin expression. Representative blots are shown from 2 independent experiments. (B and C) Cells from (A) were seeded on gelatine coated 24 well plates and infected with S. aureus at MOI 20 for 2 h. Total cell associated or recovered viable intracellular bacteria were determined by bacterial cell adhesion (B) or gentamicin protection assays (C), respectively. Values are means ± SEM from 4 independent experiments done in triplicate, n=12. Data were analyzed for statistical significance using Mann-Whitney test.

Taken together, our results demonstrate that vinculin is not required for S. aureus invasion in different cell types. Although vinculin might be recruited to the site of bacterial attachment, it has no functional role in orchestrating the integrin-mediated internalization of staphylococci into the eukaryotic host cells.


Since its discovery 32 years ago, vinculin has emerged as a key structural adaptor molecule dynamically linking integrins with the actin cytoskeleton [31]. Here we present experimental evidence that vinculin, despite its reported recruitment, is not required for the integrin-mediated internalization of Staphylococcus aureus by mammalian cells. Our conclusions are based on genetic deletion of vinculin and the complementation of the resulting vinculin-deficient cells, shRNA-mediated knock-down of vinculin, and overexpression of vinculin in different cell types, as all these different treatments do not affect host cell invasion by fibronectin-binding S. aureus.

Initially, we were puzzled by the finding that vinculin-deficient murine fibroblasts showed slightly elevated association with and uptake of fibronectin-binding S. aureus. However, the immortalized vinculin-deficient embryonic fibroblasts exhibited increased expression of integrin α5 compared to wildtype fibroblasts. It is currently unclear, if the altered expression of integrin α5 is directly caused by the lack of vinculin, which has been reported to associate with factors involved in mRNA splicing [32], or if this alteration might be due to prolonged in vitro selection and culture of the vinculin-deficient cells. Clearly, re-expression of vinculin in the vinculin-deficient cells did not alter integrin α5 expression and shRNA-mediated knock-down of vinculin in different cell types did not lead to an increase in integrin α5. Therefore, diminishing or increasing vinculin levels in different cell types did neither affect integrin α5 nor integrin-mediated uptake of S. aureus suggesting that changes observed in the vinculin -/- cells might have a secondary cause.

Interestingly, vinculin is involved in cell entry of several bacterial pathogens including Shigella flexneri and Bartonella henselae. For example, siRNA screening has revealed that vinculin and other integrin-associated molecules are critical for the formation of the characteristic invasome structure, which mediates entry of the zoonotic pathogen B. henselae (Bh) into endothelial cells [33].

In the case of S. flexneri, a leading cause of dysentery worldwide, the entry into human epithelial cells is dramatically impaired in the absence of vinculin [25]. Upon encounter of host cells, S. flexneri injects the IpaA protein. This effector protein contains three vinculin binding sites (VBS), which recognize the N-terminal vinculin head domain [34, 35]. Therefore, a single IpaA protein may bind up to three vinculin molecules. Importantly, deletion of IpaA or disruption of all three VBS in IpaA severely impair Shigella uptake demonstrating the critical role of vinculin in this entry pathway [35]. Interestingly, the VBS of IpaA are reminiscent of the vinculin binding sites found in the carboxy-terminal rod domain of the focal adhesion protein talin [36]. The eleven VBS of talin also engage the vinculin head domain and help to relief the intramolecular interactions in vinculin [18]. Accordingly, talin or IpaA binding to the vinculin head domain result in exposure of the vinculin tail domain with its binding sites for several proteins including F-actin, α-actinin, or the Arp2/3 complex [35, 37]. How vinculin in its active conformation promotes Shigella entry is not completely understood, but it has been shown that a vinculin-binding IpaA peptide can modulate the barbed end capping of actin filaments and thereby controls the rate of F-actin polymerization [38]. Similarly, conformational changes in vinculin induced by IpaA may also expose the binding site for the Arp2/3 complex, which is located in a linker region between the vinculin head and tail domain [22]. Again, this would allow Shigella to trigger actin polymerization required for efficient bacterial internalization.

A further hint, that vinculin can regulate actin polymerization during bacterial entry comes from the study of Helicobacter pylori, an extracellular pathogen, which can engage integrins without being internalized [39]. H. pylori translocates the type IV secretion system effector protein CagA into gastric epithelial cells [40]. Bacterial CagA is initially tyrosine phosphorylated and subsequently inhibits the catalytic activity of Src family protein tyrosine kinases [41, 42]. The lack of Src activity results in severely reduced phosphorylation of vinculin on residues Y100 and Y1065, disrupting interactions between vinculin and the Arp2/3 complex, and blocking actin cytoskeleton rearrangements in epithelial cells [43]. Together these results suggest that vinculin is a central host factor targeted by several bacterial effector proteins to orchestrate actin cytoskeleton rearrangements to the advantage of the pathogens.

As actin cytoskeleton dynamics are also essential for S. aureus host cell entry, yet vinculin does not seem to participate functionally in this process, regulation of actin dynamics might be achieved in a different manner during uptake of fibronectin-binding staphylococci. Previous results indicate that fibronectin-dependent, integrin-mediated internalization of S. aureus into host cells requires the integrin-associated tyrosine kinases Src and FAK [10, 15, 17]. One downstream substrate of the active FAK/Src complex is cortactin [44, 45]. Indeed, cortactin is strongly tyrosine phosphorylated upon contact of fibronectin-binding S. aureus with host cells and depletion of cortactin reduces S. aureus invasion [15]. Recent studies have demonstrated cortactin directly associates with FAK via SH3 domain-mediated binding to proline-rich sequences in FAK [45, 46]. As cortactin is also able to organize the F-actin cytoskeleton and to stimulate the actin polymerizing Arp2/3 complex [47, 48], recruitment and tyrosine phosphorylation of cortactin might direct the cytoskeletal rearrangements during S. aureus internalization, superseding vinculin function downstream of integrin engagement.

Taken together, our investigations come to the surprising conclusion that vinculin is not required for the integrin-mediated uptake of S. aureus into host cells. Despite the documented role of vinculin in dynamically linking integrins with the actin cytoskeleton, our results suggest that other cellular factors, such as the FAK-Src-cortactin signaling axis, are critical for triggering actin remodeling and bacterial entry during integrin endocytosis. It also appears likely that uptake of other pathogens, which engage integrins for host cell invasion, might be also independent of vinculin function.


Cell culture and transfection

Human embryonic kidney 293T cell line (293 cells, ACC-635, German Collection of Microorganisms and Cell Cultures, DSMZ, Braunschweig, Germany) was grown in DMEM high glucose (PAA, Pasching, Austria) supplemented with 10% calf serum (CS). Mouse embryonic fibroblasts were grown on gelatine-coated cell culture dishes in DMEM high glucose supplemented with 10% fetal calf serum (FCS; Biochrom, Berlin, Germany), non-essential amino acids and sodium pyruvate. Vinculin wildtype and vinculin -/- cells were generated from mice kindly provided by E.D. Adamson (Burnham Institute, La Jolla, CA) [49]. The fibroblasts were newly derived from mouse embryos and immortalized with SV40 largeT antigen as described [26]. All cell cultures were incubated at 37°C/5% CO2 and subcultured every 2 to 3 days. Cells were used between passage 2 and 30, counted and assayed for viability with a Casy Cell Counter (Innovatis, Bielefeld, Germany).

Transfection of 293 cells with expression vectors for GFP (Clontech) or GFP-mouse vinculin [50] was accomplished by standard calcium phosphate co-precipitation using 3.5 μg of plasmid DNA for each 10 cm culture dish as previously described [51]. Fibroblasts were transfected using Lipofectamine 2000 reagent (Invitrogen, Carlsbad, CA) according to the manufacturer’s instructions. Cells were employed in infection experiments 24 to 48 h after transfection.


Staphylococcus aureus Cowan and non-pathogenic S. carnosus TM300 have been described before [15]. Bacteria were cultured at 37°C and grown on Tryptic Soybean Broth medium (TSB; BD Biosciences, Heidelberg, Germany). Prior to the experiment bacteria were grown to reach a mid-logarithmic growth phase, washed once with PBS and used for infection at multiplicity of infection (MOI) 20 for gentamicin protection assays and MOI 50 for microscopic evaluation of extra- and intracellular bacteria.

shRNA construction and lentiviral production

Recombinant lentiviral particles were generated using the plasmids pLKO.1, pMD2.G, and psPAX2 provided by Addgene ( and maintained in E. coli STBL4 (Invitrogen, Carlsbad, CA). Using the algorithm AAGN18TT (available online at sequences that could silence expression of human or mouse vinculin were identified. According to these predictions, complementary primers were synthesized targeting human vinculin mRNA: hVinculin-shRNA-sense 5-ccggaaTCAAGCTGCTTATGAACATctcgagATGTTCATAAGCAGCTTGAtttttttg-3 and hVinculin-shRNA-anti 5-aattcaaaaaaaTCAAGCTGCTTATGAACATctcgagATGTTCATAAGCAGCTTGAtt-3; or targeting murine vinculin mRNA: mVinculin-shRNA-sense 5-ccggaaATCTGGCTGGTACATACACctcgagGTGTATGTACCAGCCAGATtttttttg-3 and mVinculin-shRNA-anti 5-aattcaaaaaaaATCTGGCTGGTACATACACctcgagGTGTATGTACCAGCCAGATtt-3. The oligos were annealed and cloned into the AgeI and EcoRI sites of pLKO.1 generating pLKO.1-sh-hvinc and pLKO.1-sh-mvinc constructs, respectively. The correct insertion of the shRNA cassette was verified by sequencing.

For lentiviral production, 2 × 106 293 cells were transiently transfected with 14 μg of the respective pLKO.1 vector together with 10 μg of packaging plasmid psPAX2 and 7 μg of envelope-coding plasmid pMD2.G. 48 h later, the virus-containing cell culture supernatant was collected, centrifuged at 2000 rpm at 4°C for 7 min and filtered through a 0.45 μm pore-size filter. 6 ml of the cleared viral supernatant was used to transduce 293 cells or fibroblasts in 10 cm culture dishes. After 24 h, puromycin (0.45 μg/ml for 293 cells and 2.5 μg/ml for fibroblasts) was added and the puromycin-resistant stable cell population was used in experiments after 7 days of selection.

Quantification of surface integrin expression by flow cytometry

Integrin α5 (clone 5H10-27(MFR5)) and integrin αv (clone RMV-7) antibodies were purchased from BD Biosciences. Integrin β1 (clone CBL1333F) was obtained from Cymbus Biotechnology (London, UK) and integrin β3 antibody (clone 2C9.G3) from eBioscience (San Diego, CA). Secondary antibodies (biotin-SP-conjugated goat α-mouse IgG, biotin-SP-conjugated goat α-rat IgG), streptavidin–FITC and streptavidin-rhodamine (TRITC) were purchased from Jackson ImmunoResearch (West Grove, PA). For quantification of surface integrin expression, suspended fibroblasts were incubated in suspension medium (DMEM containing 0.25% BSA) for 40 min at 37°C. Then, 2 × 105 cells were incubated with appropriate primary antibodies (diluted 1:500) in FACS buffer (5% heat-inactivated FCS, 1% sodium azide in PBS) for 1 h at 4°C. After washing, secondary antibodies were applied for 1h at 4°C, and after washing, samples were analyzed by flow cytometry (LSRII, BD Biosciences).

qRT-PCR evaluation of integrin mRNA levels

Total RNA was isolated from vinculin wild type and vinculin -/- cells cells using RNeasy Mini Kit (Qiagen, Hilden, Germany). Reverse transcription was performed on 1 μg total RNA. Quantitative real-time PCR was conducted with the sensiMixPlus SYBR Kit (Quantace, Germany) with the following cycle conditions: 95°C for 10 min followed by 40 cycles at 95°C for 10 s, 60°C for 20 s, and 72°C for 20 s. Relative expression of αv-, α5-, β1-, β3-integrins was normalized using glyceraldehyde-3-phosphate dehydrogenase (GAPDH) according to the method by Livak and Schmittgen [52]. The primers used were: mouse αv-integrin (forward: 5-TTGGG GACGA CAACC CTCTG ACAC-3; reverse: 5-TGCGG CGGGA TAGAA ACGAT GAG-3); mouse α5-integrin (forward: 5- CACTT GGCTT CAGGG CATTT C-3; reverse: 5- CAACT ACACC CCCAA CTCAC AGG-3); mouse β1-integrin (forward: 5- TCTCA CCAAA GTAGA AAGCA GGGA-3; reverse: 5- ACGAT AGCTT CATTG TTGCC ATTC-3); mouse β3-integrin (forward: 5- GCTTT GGGGC CTTCG TGGAC AA-3; reverse: 5- CATGG GCAAG CAGGC ATTCT TCAT-3); and mouse GAPDH (forward: 5- TGCAC CACCA ACTGCT TAG-3; reverse: 5- GGATG CAGGG ATGAT GTTC-3).

Gentamicin protection assay

Briefly, 2 × 105 293 cells or 1 × 105 fibroblasts were seeded on gelatine coated (0.1% in PBS) 24 well plates. Cells were infected with 20 bacteria per cell (MOI 20) for 2 h. To evaluate the number of intracellular bacteria, the medium was replaced with DMEM containing 50 μg/ml gentamicin. After incubation for 1 h at 37°C, intracellular bacteria were released by treatment with 0.5% saponin in PBS for 10 min at 37°C. Samples were diluted in PBS and plated on TSB agar plates for determination of the recovered colony forming units (cfu). Total cell associated bacteria were determined in separate samples by omitting the incubation with gentamicin and washed once (293) or twice (fibroblasts) with PBS before lysis by 0.5% saponin in PBS.

Fluorescence staining of vinculin and total internal reflection fluorescence (TIRF) microscopy

3 × 104 vinculin WT and vinculin -/- cells were plated on 4 μg/ml fibronectin coated glass bottom imaging dishes. Next day, cells were washed once with PBS+/+ (PBS supplemented with Ca2+ and Mg2+) and fixed with 4% paraformaldehyde for 20 min. For vinculin staining, fixed samples were washed twice and permeabilized for 10 min in Triton X100 solution (0.5% in PBS). After three washing steps unspecific binding sites were saturated by incubating the samples with blocking buffer (10% heat inactivated FCS in PBS+/+) for 10 min. Then, samples were incubated with 1:500 diluted monoclonal mouse α-human vinculin antibody (clone hVIN1; Sigma-Aldrich, Steinheim, Germany) in blocking buffer for 30 min. Samples were washed three times, blocked for 10 min and incubated with biotin-SP-conjugated goat α-mouse IgG antibody (1:500) for 30 min in blocking buffer. Samples were washed again and incubated for 30 min with streptavidin–FITC (1:500) in the dark. All fluorescence staining steps were performed at room temperature. In addition, samples were co-stained for integrin β1 (clone HMβ1-1; BioLegend, San Diego, CA) together with rhodamine conjugated goat-α-armenian hamster IgG antibody (Jackson ImmunoResearch) or for active integrin β1 (clone 9EG7, recognizing the active conformation of integrin β1) together with rhodamine conjugated goat-α-rat IgG (Jackson ImmunoResearch). Antibodies were diluted 1:300 and samples were analyzed by Total Internal Reflection Fluorescence (TIRF) microscopy. Images were acquired using a Leica AF6000LX TIRF system (Leica, Mannheim, Germany) equipped with 100x/1.46 NA Oil HCX PL Apo objective and EMCCD camera (CascadeII:512). Images were digitally processed using ImageJ.

Cell lysis and western blotting

Cell lysis and Western blotting were performed as described [51] with some modifications. Briefly, protein concentration was assessed using Pierce bicinchoninic assay kit (Thermo Fisher Scientific, Waltham, MA). Equal amounts of proteins were loaded on SDS-PAGE gels. Antibodies against FAK (clone 77) and paxillin (clone 177) were from BD Biosciences, against talin (clone H-300) from Santa Cruz (Santa Cruz, CA) and against vinculin (clone hVIN1) was from Sigma-Aldrich. Antibody against β-tubulin (E-7) and Src were purified from hybridoma cell supernatants. Goat anti-mouse IgG coupled to HRP was purchased from Jackson ImmunoResearch.

Staining of extra- and intracellular bacteria and fluorescence microscopy evaluation

3 × 104 vinculin -/- cells were seeded on gelatine coated acid washed glass cover slips in 24 well plates. Next day, cells were transfected with GFP or GFP-mouse vinculin using Lipofectamine 2000. 24 h after transfection, cell culture medium was exchanged and cells were infected with Staphylococcus aureus (MOI 50) for 2 h, washed twice with PBS+/+ and fixed with 4% paraformaldehyde in PBS for 20 min at RT, incubated in blocking buffer for 10 min. Extracellular bacteria were stained using rabbit polyclonal α-staphylococcal serum diluted in blocking buffer (45 min at RT). Afterwards, samples were washed three times and incubated with goat α-rabbit IgG-Cy5 (Jackson Immunoresearch) in the dark for 30 min. After three washing steps, cells were permeabilized using 0.5% Triton/PBS for 10 min, washed three times and blocked additionally for 10 min. Then, after incubation with rabbit polyclonal α-staphylococcal serum, samples were washed three times and incubated with goat α-rabbit IgG coupled to Cy3 in the dark for 30 min. Finally, after three washes with PBS, the coverslips were mounted in embedding medium (DaKo, Glostrup, Denmark) on glass slides and sealed with nail polish. Images were acquired with a Leica AF6000LX fluorescence microscope and processed with ImageJ.


Infection and flow cytometry experiments were performed two to five times, and data were presented as mean ± SEM. Differences in adherence and internalization of staphylococci were analyzed by Mann-Whitney test or for more than 2 groups of analysis by Kruskal-Wallis test. In all analyses, p value <0.05 was considered statistically significant.


This study demonstrates that the focal adhesion protein vinculin does not contribute to the integrin-mediated uptake of fibronectin-binding S. aureus. This result is unexpected given the critical role of vinculin as a linker between integrins and F-actin.


  1. 1.

    Lowy FD: Staphylococcus aureus infections. N Engl J Med. 1998, 339 (8): 520-532. 10.1056/NEJM199808203390806.

    CAS  Article  PubMed  Google Scholar 

  2. 2.

    Henderson B, Nair S, Pallas J, Williams MA: Fibronectin: a multidomain host adhesin targeted by bacterial fibronectin-binding proteins. FEMS Microbiol Rev. 2011, 35 (1): 147-200. 10.1111/j.1574-6976.2010.00243.x.

    CAS  Article  PubMed  Google Scholar 

  3. 3.

    Hauck CR, Ohlsen K: Sticky connections: extracellular matrix protein recognition and integrin-mediated cellular invasion by Staphylococcus aureus. Curr Opin Microbiol. 2006, 9 (1): 5-11. 10.1016/j.mib.2005.12.002.

    CAS  Article  PubMed  Google Scholar 

  4. 4.

    Schwarz-Linek U, Hook M, Potts JR: The molecular basis of fibronectin-mediated bacterial adherence to host cells. Mol Microbiol. 2004, 52 (3): 631-641. 10.1111/j.1365-2958.2004.04027.x.

    CAS  Article  PubMed  Google Scholar 

  5. 5.

    Sinha B, Francois PP, Nusse O, Foti M, Hartford OM, Vaudaux P, Foster TJ, Lew DP, Herrmann M, Krause KH: Fibronectin-binding protein acts as Staphylococcus aureus invasin via fibronectin bridging to integrin alpha5beta1. Cell Microbiol. 1999, 1 (2): 101-117. 10.1046/j.1462-5822.1999.00011.x.

    CAS  Article  PubMed  Google Scholar 

  6. 6.

    Fowler T, Wann ER, Joh D, Johansson S, Foster TJ, Hook M: Cellular invasion by Staphylococcus aureus involves a fibronectin bridge between the bacterial fibronectin-binding MSCRAMMs and host cell beta1 integrins. Eur J Cell Biol. 2000, 79 (10): 672-679. 10.1078/0171-9335-00104.

    CAS  Article  PubMed  Google Scholar 

  7. 7.

    Dziewanowska K, Patti JM, Deobald CF, Bayles KW, Trumble WR, Bohach GA: Fibronectin binding protein and host cell tyrosine kinase are required for internalization of Staphylococcus aureus by epithelial cells. Infect Immun. 1999, 67 (9): 4673-4678.

    PubMed Central  CAS  PubMed  Google Scholar 

  8. 8.

    Massey RC, Kantzanou MN, Fowler T, Day NP, Schofield K, Wann ER, Berendt AR, Hook M, Peacock SJ: Fibronectin-binding protein A of Staphylococcus aureus has multiple, substituting, binding regions that mediate adherence to fibronectin and invasion of endothelial cells. Cell Microbiol. 2001, 3 (12): 839-851. 10.1046/j.1462-5822.2001.00157.x.

    CAS  Article  PubMed  Google Scholar 

  9. 9.

    Jett BD, Gilmore MS: Internalization of Staphylococcus aureus by human corneal epithelial cells: role of bacterial fibronectin-binding protein and host cell factors. Infect Immun. 2002, 70 (8): 4697-4700. 10.1128/IAI.70.8.4697-4700.2002.

    PubMed Central  CAS  Article  PubMed  Google Scholar 

  10. 10.

    Agerer F, Michel A, Ohlsen K, Hauck CR: Integrin-mediated invasion of Staphylococcus aureus into human cells requires Src family protein tyrosine kinases. J Biol Chem. 2003, 278 (43): 42524-42531. 10.1074/jbc.M302096200.

    CAS  Article  PubMed  Google Scholar 

  11. 11.

    Kuypers JM, Proctor RA: Reduced adherence to traumatized rat heart valves by a low-fibronectin-binding mutant of Staphylococcus aureus. Infect Immun. 1989, 57 (8): 2306-2312.

    PubMed Central  CAS  PubMed  Google Scholar 

  12. 12.

    Brouillette E, Talbot BG, Malouin F: The fibronectin-binding proteins of Staphylococcus aureus may promote mammary gland colonization in a lactating mouse model of mastitis. Infect Immun. 2003, 71 (4): 2292-2295. 10.1128/IAI.71.4.2292-2295.2003.

    PubMed Central  CAS  Article  PubMed  Google Scholar 

  13. 13.

    Que YA, Haefliger JA, Piroth L, Francois P, Widmer E, Entenza JM, Sinha B, Herrmann M, Francioli P, Vaudaux P: Fibrinogen and fibronectin binding cooperate for valve infection and invasion in Staphylococcus aureus experimental endocarditis. J Exp Med. 2005, 201 (10): 1627-1635. 10.1084/jem.20050125.

    PubMed Central  CAS  Article  PubMed  Google Scholar 

  14. 14.

    Menzies BE: The role of fibronectin binding proteins in the pathogenesis of Staphylococcus aureus infections. Curr Opin Infect Dis. 2003, 16 (3): 225-229. 10.1097/00001432-200306000-00007.

    CAS  Article  PubMed  Google Scholar 

  15. 15.

    Agerer F, Lux S, Michel A, Rohde M, Ohlsen K, Hauck CR: Cellular invasion by Staphylococcus aureus reveals a functional link between focal adhesion kinase and cortactin in integrin-mediated internalisation. J Cell Sci. 2005, 118 (10): 2189-2200. 10.1242/jcs.02328.

    CAS  Article  PubMed  Google Scholar 

  16. 16.

    Schroder A, Schroder B, Roppenser B, Linder S, Sinha B, Fassler R, Aepfelbacher M: Staphylococcus aureus fibronectin binding protein-a induces motile attachment sites and complex actin remodeling in living endothelial Cells. Mol Biol Cell. 2006, 17 (12): 5198-5210. 10.1091/mbc.E06-05-0463.

    PubMed Central  Article  PubMed  Google Scholar 

  17. 17.

    Fowler T, Johansson S, Wary KK, Hook M: Src kinase has a central role in in vitro cellular internalization of Staphylococcus aureus. Cell Microbiol. 2003, 5 (6): 417-426. 10.1046/j.1462-5822.2003.00290.x.

    CAS  Article  PubMed  Google Scholar 

  18. 18.

    Ziegler WH, Liddington RC, Critchley DR: The structure and regulation of vinculin. Trends Cell Biol. 2006, 16 (9): 453-460. 10.1016/j.tcb.2006.07.004.

    CAS  Article  PubMed  Google Scholar 

  19. 19.

    Geiger B, Spatz JP, Bershadsky AD: Environmental sensing through focal adhesions. Nat Rev Mol Cell Biol. 2009, 10 (1): 21-33. 10.1038/nrm2593.

    CAS  Article  PubMed  Google Scholar 

  20. 20.

    Bakolitsa C, Cohen DM, Bankston LA, Bobkov AA, Cadwell GW, Jennings L, Critchley DR, Craig SW, Liddington RC: Structural basis for vinculin activation at sites of cell adhesion. Nature. 2004, 430 (6999): 583-586. 10.1038/nature02610.

    CAS  Article  PubMed  Google Scholar 

  21. 21.

    Humphries JD, Wang P, Streuli C, Geiger B, Humphries MJ, Ballestrem C: Vinculin controls focal adhesion formation by direct interactions with talin and actin. J Cell Biol. 2007, 179 (5): 1043-1057. 10.1083/jcb.200703036.

    PubMed Central  CAS  Article  PubMed  Google Scholar 

  22. 22.

    DeMali KA, Barlow CA, Burridge K: Recruitment of the Arp2/3 complex to vinculin: coupling membrane protrusion to matrix adhesion. J Cell Biol. 2002, 159 (5): 881-891. 10.1083/jcb.200206043.

    PubMed Central  CAS  Article  PubMed  Google Scholar 

  23. 23.

    Le Clainche C, Dwivedi SP, Didry D, Carlier MF: Vinculin is a dually regulated actin filament barbed end-capping and side-binding protein. J Biol Chem. 2010, 285 (30): 23420-23432. 10.1074/jbc.M110.102830.

    PubMed Central  CAS  Article  PubMed  Google Scholar 

  24. 24.

    Bourdet-Sicard R, Rudiger M, Jockusch BM, Gounon P, Sansonetti PJ, Nhieu GT: Binding of the Shigella protein IpaA to vinculin induces F-actin depolymerization. EMBO J. 1999, 18 (21): 5853-5862. 10.1093/emboj/18.21.5853.

    PubMed Central  CAS  Article  PubMed  Google Scholar 

  25. 25.

    Tran Van Nhieu G, Ben-Ze'ev A, Sansonetti PJ: Modulation of bacterial entry into epithelial cells by association between vinculin and the Shigella IpaA invasin. EMBO J. 1997, 16: 2717-2729. 10.1093/emboj/16.10.2717.

    PubMed Central  CAS  Article  PubMed  Google Scholar 

  26. 26.

    Mierke CT, Kollmannsberger P, Zitterbart DP, Diez G, Koch TM, Marg S, Ziegler WH, Goldmann WH, Fabry B: Vinculin facilitates cell invasion into three-dimensional collagen matrices. J Biol Chem. 2010, 285 (17): 13121-13130. 10.1074/jbc.M109.087171.

    PubMed Central  CAS  Article  PubMed  Google Scholar 

  27. 27.

    Xu W, Coll JL, Adamson ED: Rescue of the mutant phenotype by reexpression of full-length vinculin in null F9 cells; effects on cell locomotion by domain deleted vinculin. J Cell Sci. 1998, 111 (Pt 11): 1535-1544.

    CAS  PubMed  Google Scholar 

  28. 28.

    Saunders RM, Holt MR, Jennings L, Sutton DH, Barsukov IL, Bobkov A, Liddington RC, Adamson EA, Dunn GA, Critchley DR: Role of vinculin in regulating focal adhesion turnover. Eur J Cell Biol. 2006, 85 (6): 487-500. 10.1016/j.ejcb.2006.01.014.

    CAS  Article  PubMed  Google Scholar 

  29. 29.

    Heesemann J, Laufs R: Double immunofluorescence microscopic technique for accurate differentiation of extracellularly and intracellularly located bacteria in cell culture. J Clin Microbiol. 1985, 22: 168-175.

    PubMed Central  CAS  PubMed  Google Scholar 

  30. 30.

    Agerer F, Waeckerle S, Hauck CR: Microscopic quantification of bacterial invasion by a novel antibody-independent staining method. J Microbiol Meth. 2004, 59 (1): 23-32. 10.1016/j.mimet.2004.05.008.

    CAS  Article  Google Scholar 

  31. 31.

    Ziegler WH, Gingras AR, Critchley DR, Emsley J: Integrin connections to the cytoskeleton through talin and vinculin. Biochem Soc Trans. 2008, 36 (Pt 2): 235-239.

    CAS  Article  PubMed  Google Scholar 

  32. 32.

    Lahmann I, Fabienke M, Henneberg B, Pabst O, Vauti F, Minge D, Illenberger S, Jockusch BM, Korte M, Arnold HH: The hnRNP and cytoskeletal protein raver1 contributes to synaptic plasticity. Exp Cell Res. 2008, 314 (5): 1048-1060. 10.1016/j.yexcr.2007.10.022.

    CAS  Article  PubMed  Google Scholar 

  33. 33.

    Truttmann MC, Misselwitz B, Huser S, Hardt WD, Critchley DR, Dehio C: Bartonella henselae engages inside-out and outside-in signaling by integrin beta1 and talin1 during invasome-mediated bacterial uptake. J Cell Sci. 2011, 124 (Pt 21): 3591-3602.

    CAS  Article  PubMed  Google Scholar 

  34. 34.

    Izard T, Tran Van Nhieu G, Bois PR: Shigella applies molecular mimicry to subvert vinculin and invade host cells. J Cell Biol. 2006, 175 (3): 465-475. 10.1083/jcb.200605091.

    PubMed Central  CAS  Article  PubMed  Google Scholar 

  35. 35.

    Park H, Valencia-Gallardo C, Sharff A, Tran Van Nhieu G, Izard T: Novel vinculin binding site of the IpaA invasin of Shigella. J Biol Chem. 2011, 286 (26): 23214-23221. 10.1074/jbc.M110.184283.

    PubMed Central  CAS  Article  PubMed  Google Scholar 

  36. 36.

    Gingras AR, Ziegler WH, Frank R, Barsukov IL, Roberts GC, Critchley DR, Emsley J: Mapping and consensus sequence identification for multiple vinculin binding sites within the talin rod. J Biol Chem. 2005, 280 (44): 37217-37224. 10.1074/jbc.M508060200.

    CAS  Article  PubMed  Google Scholar 

  37. 37.

    Hamiaux C, van Eerde A, Parsot C, Broos J, Dijkstra BW: Structural mimicry for vinculin activation by IpaA, a virulence factor of Shigella flexneri. EMBO Rep. 2006, 7 (8): 794-799.

    PubMed Central  CAS  PubMed  Google Scholar 

  38. 38.

    Ramarao N, Le Clainche C, Izard T, Bourdet-Sicard R, Ageron E, Sansonetti PJ, Carlier MF, Tran Van Nhieu G: Capping of actin filaments by vinculin activated by the Shigella IpaA carboxyl-terminal domain. FEBS Lett. 2007, 581 (5): 853-857. 10.1016/j.febslet.2007.01.057.

    CAS  Article  PubMed  Google Scholar 

  39. 39.

    Kwok T, Zabler D, Urman S, Rohde M, Hartig R, Wessler S, Misselwitz R, Berger J, Sewald N, Konig W: Helicobacter exploits integrin for type IV secretion and kinase activation. Nature. 2007, 449 (7164): 862-866. 10.1038/nature06187.

    CAS  Article  PubMed  Google Scholar 

  40. 40.

    Backert S, Selbach M: Role of type IV secretion in Helicobacter pylori pathogenesis. Cell Microbiol. 2008, 10 (8): 1573-1581. 10.1111/j.1462-5822.2008.01156.x.

    CAS  Article  PubMed  Google Scholar 

  41. 41.

    Selbach M, Moese S, Hauck CR, Meyer TF, Backert S: Src Is the Kinase of the Helicobacter pylori CagA Protein in Vitro and in Vivo. J Biol Chem. 2002, 277 (9): 6775-6778. 10.1074/jbc.C100754200.

    CAS  Article  PubMed  Google Scholar 

  42. 42.

    Selbach M, Moese S, Hauck CR, Meyer TF, Backert S: The Helicobacter pylori CagA protein induces cortactin dephosphorylation and actin rearrangements by c-Src inactivation. EMBO J. 2003, 22: 515-528. 10.1093/emboj/cdg050.

    PubMed Central  CAS  Article  PubMed  Google Scholar 

  43. 43.

    Moese S, Selbach M, Brinkmann V, Karlas A, Haimovich B, Backert S, Meyer TF: The Helicobacter pylori CagA protein disrupts matrix adhesion of gastric epithelial cells by dephosphorylation of vinculin. Cell Microbiol. 2007, 9 (5): 1148-1161. 10.1111/j.1462-5822.2006.00856.x.

    CAS  Article  PubMed  Google Scholar 

  44. 44.

    Wu H, Parsons JT: Cortactin, an 80/85-kilodalton pp60src substrate, is a filamentous actin-binding protein enriched in the cell cortex. J Cell Biol. 1993, 120 (6): 1417-1426. 10.1083/jcb.120.6.1417.

    CAS  Article  PubMed  Google Scholar 

  45. 45.

    Wang W, Liu Y, Liao K: Tyrosine phosphorylation of cortactin by the FAK-Src complex at focal adhesions regulates cell motility. BMC Cell Biol. 2011, 12: 49-10.1186/1471-2121-12-49.

    PubMed Central  CAS  Article  PubMed  Google Scholar 

  46. 46.

    Tegtmeyer N, Wittelsberger R, Hartig R, Wessler S, Martinez-Quiles N, Backert S: Serine phosphorylation of cortactin controls focal adhesion kinase activity and cell scattering induced by Helicobacter pylori. Cell Host Microbe. 2011, 9 (6): 520-531. 10.1016/j.chom.2011.05.007.

    CAS  Article  PubMed  Google Scholar 

  47. 47.

    Weaver AM, Heuser JE, Karginov AV, Lee WL, Parsons JT, Cooper JA: Interaction of cortactin and N-WASp with Arp2/3 complex. Curr Biol. 2002, 12 (15): 1270-1278. 10.1016/S0960-9822(02)01035-7.

    CAS  Article  PubMed  Google Scholar 

  48. 48.

    Weed SA, Karginov AV, Schafer DA, Weaver AM, Kinley AW, Cooper JA, Parsons JT: Cortactin localization to sites of actin assembly in lamellipodia requires interactions with F-actin and the Arp2/3 complex [In Process Citation]. J Cell Biol. 2000, 151 (1): 29-40. 10.1083/jcb.151.1.29.

    PubMed Central  CAS  Article  PubMed  Google Scholar 

  49. 49.

    Xu W, Baribault H, Adamson ED: Vinculin knockout results in heart and brain defects during embryonic development. Development. 1998, 125 (2): 327-337.

    CAS  PubMed  Google Scholar 

  50. 50.

    Chandrasekar I, Stradal TE, Holt MR, Entschladen F, Jockusch BM, Ziegler WH: Vinculin acts as a sensor in lipid regulation of adhesion-site turnover. J Cell Sci. 2005, 118 (Pt 7): 1461-1472.

    CAS  Article  PubMed  Google Scholar 

  51. 51.

    Schmitter T, Agerer F, Peterson L, Muenzner P, Hauck CR: Granulocyte CEACAM3 is a phagocytic receptor of the innate immune system that mediates recognition and elimination of human-specific pathogens. J Exp Med. 2004, 199: 35-46.

    PubMed Central  CAS  Article  PubMed  Google Scholar 

  52. 52.

    Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-ΔΔ C(T)) Method. Methods. 2001, 25 (4): 402-408. 10.1006/meth.2001.1262.

    CAS  Article  PubMed  Google Scholar 

Download references


We thank NI Dierdorf for designing the shRNAs, C. Hoffmann for preliminary experiments on this project, S. Illenberger for the EGFP-vinculin construct and S. Feindler-Boeckh for the excellent technical support. AB is recipient of a fellowship according to the LGFG, Baden-Württemberg, and acknowledges support by the Zukunftskolleg of the University of Konstanz. This study was supported by funds from the DFG Ha 2856/5-1 (to CRH). The funding body had no influence on experimental design, the collection, analysis, and interpretation of data; the writing of the manuscript; or the decision to submit the manuscript for publication.

Author information



Corresponding author

Correspondence to Christof R Hauck.

Additional information

Competing interests

The authors declare that they have no competing interests.

Authors’ contributions

MB and CRH conceived the study and designed the experiments, MB and YS performed the experiments, AB advised and performed microscopic determinations, SW generated the vinculin knock down cells, WHZ provided reagents and advised on the manuscript, MB and CRH wrote the paper. All authors read and approved the final manuscript.

Electronic supplementary material

Authors’ original submitted files for images

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Borisova, M., Shi, Y., Buntru, A. et al. Integrin-mediated internalization of Staphylococcus aureus does not require vinculin. BMC Cell Biol 14, 2 (2013).

Download citation


  • Staphylococcus aureus
  • Bacterial adhesion
  • Endocytosis
  • Fibronectin
  • Host cell invasion
  • Integrin
  • Vinculin